Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9 + T cells

作者：Hongmei Chen, Xiuxiu Cong, Chenxi Wu, Xuan Wu, Jialiang Wang, Kuirong Mao, Jie Li, Ge Zhu, Feiqi Liu, Xiandi Meng, Jia Song, Xu Sun, Xin Wang, Shuhan Liu, Zhang Shi, Xianzhu Yang, Yanqiu Song, Yong-Guang Yang, Tianmeng Sun · 发表于：Science Advances · 年份：2020 · DOI：10.1126/sciadv.aax4690 · 被引用次数：87 · 研究领域：Immunotherapy and Immune Responses、Phagocytosis and Immune Regulation、CAR-T cell therapy research

This study offers an effective strategy to enhance immunotherapy by promoting CCR9 + CD8 + T cell tumor infiltration.